Fibristal 5MG (2020-09-24) Sep 24, 2020 · Published by Health Canada · Official notice
Share
Alert type : Drug Recall
Category : Drugs
Issue : Product Safety
Audience : General Public, Healthcare Professionals, Hospitals
Department : Health Canada
Hazard classification : Type II
Fibristal 5MG
Lot or serial number Companies Brand name DIN, NPN, DIN-HIM Dosage form Strength T7B236A Recalling Firm Allergan Inc. 500 Enterprise Blvd. Suite 500 Markham L65 0B5 Ontario CANADA Marketing Authorization Holder Allergan Inc. 500 Enterprise Blvd. Suite 500 Markham L65 0B5 Ontario CANADA Fibristal 5MG DIN 02408163 Tablet Ulipristal Acetate 5MG
During post-market experience, rare cases of liver injury, including cases of serious liver impairment requiring liver transplantation, were reported in patients using ulipristal acetate 5mg.
Wholesalers, Healthcare establishments, Physicians